Stammdaten
Unternehmen
| Name | TransMedics Group, Inc. |
|---|---|
| Ticker | TMDX |
| CIK | 0001756262 |
Branche
| SIC-Code | 3845 |
|---|---|
| Beschreibung | Electromedical & Electrotherapeutic Apparatus |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | TransMedics Group, Inc. |
Status
| Zuletzt geprüft | 2026-03-23 02:19:53.989368 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | Hernandez Gerardo | Officer, Chief Financial Officer | Open Market Sale | -1,324 | 147.21 | -194,906.04 | -42,5% | |
| 2026-03-04 | Lovell Stephanie | Director | Open Market Sale | -1,193 | 149.62 | -178,496.66 | -38,9% | |
| 2026-03-04 | Weill David | Director | Open Market Sale | -3,571 | 146.82 | -524,294.22 | -114,4% | |
| 2026-03-04 | Hernandez Gerardo | Officer, Chief Financial Officer | Open Market Sale | -5,912 | 147.21 | -870,305.52 | -189,9% | |
| 2026-03-02 | Corcoran Nicholas | Officer, See remarks | Open Market Sale | -2,966 | 139.12 | -412,629.92 | -90,0% | |
| 2026-03-02 | Hernandez Gerardo | Officer, Chief Financial Officer | Open Market Sale | -375 | 139.12 | -52,170.00 | -11,4% | |
| 2026-03-02 | Ranganath Anil P. | Officer, See remarks | Open Market Sale | -864 | 139.12 | -120,199.68 | -26,2% | |
| 2025-12-04 | Hernandez Gerardo | Officer, Chief Financial Officer | Open Market Sale | -920 | 139.62 | -128,450.40 | -28,0% | |
| 2025-12-03 | Weill David | Director | Open Market Sale | -5,000 | 138.64 | -693,200.00 | -151,3% | |
| 2025-11-25 | Ranganath Anil P. | Officer, See remarks | Open Market Sale | -3,000 | 145.22 | -435,660.00 | -95,1% | |
| 2025-11-17 | Hassanein Waleed H | Director, Officer, President & CEO | Open Market Purchase | 8,775 | 114.00 | 1,000,350.00 | +218,3% | |
| 2025-10-29 | Basile Edward M | Director | Open Market Sale | -4,142 | 130.45 | -540,323.90 | -117,9% | |
| 2025-08-07 | Hassanein Waleed H | Director, Officer, President & CEO | Open Market Purchase | 6,617 | 116.08 | 768,101.36 | +167,6% | |
| 2025-08-07 | Hassanein Waleed H | Director, Officer, President & CEO | Open Market Purchase | 1,858 | 116.85 | 217,107.30 | +47,4% | |
| 2025-08-06 | Hassanein Waleed H | Director, Officer, President & CEO | Open Market Purchase | 8,400 | 118.68 | 996,912.00 | +217,5% | |
| 2025-08-04 | Basile Edward M | Director | Open Market Sale | -4,143 | 125.51 | -519,987.93 | -113,5% | |
| 2025-06-09 | Ranganath Anil P. | Officer, See remarks | Open Market Sale | -686 | 139.80 | -95,902.80 | -20,9% | |
| 2025-05-27 | Basile Edward M | Director | Open Market Sale | -5,000 | 126.45 | -632,250.00 | -138,0% | |
| 2025-05-23 | Weill David | Director | Open Market Sale | -732 | 123.88 | -90,680.16 | -19,8% | |
| 2025-05-09 | Basile Edward M | Director | Open Market Sale | -6,000 | 115.63 | -693,780.00 | -151,4% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.